Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Impact in Liver Resection
NCT00151671Phase 3Terminated
- Sponsor
- CHU Rennes
- Start
- Apr 2003
- Primary completion
- Apr 2008
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of IMPACT in liver cancer, Cirrhosis, Liver Fibrosis (LF), sponsored by CHU Rennes. Started Apr 2003; status: terminated.
02
Drugs
IMPACT
03
Conditions
liver cancerCirrhosisLiver Fibrosis (LF)
Beyond the preview
Go deeper on NCT00151671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00151671.